Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | STAT3 | P40763 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | AGER | Q15109 | 1/20 | 0.42 |
| ▸ | VDR | P11473 | 1/20 | 0.41 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2757584 | 1.00 | GAA (0.45) | GAACA1CA9CA12ALDH1A1 | |
| SCHEMBL5605462 | 0.96 | CA12 (0.43) | GAACA1CA9CA12ALDH1A1 | |
| SCHEMBL28459992 | 0.95 | ALDH1A1 (0.46) | GAACA1CA9CA12ALDH1A1 | |
| SCHEMBL499508 | 0.90 | ALDH1A1 (0.46) | GAACA1CA9CA12ALDH1A1 | |
| SCHEMBL484303 | 0.90 | ALDH1A1 (0.46) | GAACA1CA9CA12ALDH1A1 | |
| SCHEMBL13020456 | 0.89 | ALDH1A1 (0.44) | GAACA1CA9CA12ALDH1A1 | |
| SCHEMBL57036 | 0.89 | ALDH1A1 (0.44) | GAACA1CA9CA12ALDH1A1 | |
| SCHEMBL241884 | 0.88 | CA1 (0.52) | GAACA1CA9CA12ALDH1A1 | |
| SCHEMBL3838686 | 0.87 | ALDH1A1 (0.43) | GAACA1CA9CA12ALDH1A1 | |
| SCHEMBL8402278 | 0.86 | ALDH1A1 (0.42) | GAACA1CA9CA12ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 989 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117865858-A | Novel PET imaging agent targeting cannabinoid type 2 receptor, preparation method and application thereof | 浙江大学 | 2024-04-12 | — | — | CN | claimed |
| CN-117199523-A | Electrolyte, secondary battery and electric equipment | 欣旺达动力科技股份有限公司 | 2023-12-08 | — | — | CN | claimed |
| US-11242314-B2 | Synthesizing pet tracers using [F-18]sulfonyl fluoride as a source of [F-18]fluoride | WASHINGTON UNIVERSITY (US) | 2022-02-08 | — | — | US | claimed |
| CN-111233834-B | FAK-targeting compound and markers thereof, and preparation methods and applications of FAK-targeting compound and markers | 北京师范大学 | 2021-08-31 | — | — | CN | claimed |
| CN-112778838-A | Inorganic nano material printing ink and preparation method thereof | 广东绿展科技有限公司 | 2021-05-11 | — | — | CN | claimed |
| US-20170197912-A1 | SYNTHESIZING PET TRACERS USING [F-18]SULFONYL FLUORIDE AS A SOURCE OF [F-18]FLUORIDE | WASHINGTON UNIVERSITY (US) | 2017-07-13 | — | — | US | claimed |
| CN-105461708-A | Quinazoline tyrosine kinase inhibitor, and preparation method and application thereof | SHANGHAI SUN-SAIL PHARMACEUTICAL SCIENCE & TECH CO LTD | 2016-04-06 | — | — | CN | claimed |
| US-20150367005-A1 | METHOD OF SYNTHESIZING FLUORINE-18 LABELED RADIOPHARMACEUTICALS IN ETHANOL AND WATER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2015-12-24 | — | — | US | claimed |
| CN-101709060-B | F-triazole ring-polyethylene glycol-metronidazole compound and preparation method thereof | UNIV BEIJING NORMAL | 2013-05-01 | — | — | CN | claimed |
| CN-101648899-B | New synthetic method of PET imaging agent L-5-18FETP | PEKING UNION MEDICAL COLLEGE HOSPITAL CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2012-02-22 | — | — | CN | claimed |
| CN-101709060-A | F-triazole ring-polyethylene glycol-metronidazole compound and preparation method thereof | UNIV BEIJING NORMAL | 2010-05-19 | — | — | CN | claimed |
| CN-101648899-A | New synthetic method of PET imaging agent L-5-<18>FETP | PEKING UNION MEDICAL COLLEGE H | 2010-02-17 | — | — | CN | claimed |
| WO-2008132211-A1 | AMINO-QUINAZOLINONE DERIVATIVES FOR USE AS RADIOTRACERS AND IMAGING AGENTS | NOVARTIS AG (CH) | 2008-11-06 | — | — | WO | claimed |
| EP-0195135-B1 | A PROCESS FOR THE PREPARATION OF QUINOLINE CARBOXYLIC ACID DERIVATIVES | KYORIN SEIYAKU KABUSHIKI KAISHA (JP) | 1992-06-17 | — | — | EP | claimed |
| WO-2026098672-A1 | BIAZACYCLOALKANE MENIN-MLL PROTEIN INHIBITORS, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | 赛诺哈勃药业（成都）有限公司 | 2026-05-15 | — | — | WO | disclosed |
| EP-3687551-B1 | FLUORO SUBSTITUTED PORPHYRIN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS OF PREPARING AND USING THE SAME | UNIV DUKE (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4713330-A1 | TRICYCLIC COMPOUNDS AND USES THEREOF | HUTCHMED Limited (CN) | 2026-03-25 | — | — | EP | disclosed |
| EP-0031237-B1 | QUINAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, COMPOSITIONS CONTAINING THEM AND THEIR USE AS ANTI-CANCER AGENTS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1984-10-17 | — | — | EP | disclosed |
| US-4382937-A | Naphthyridine derivatives and their use as anti-bacterials | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1983-05-10 | — | — | US | disclosed |
| EP-0031237-A1 | Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1981-07-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170197912-A1 | SYNTHESIZING PET TRACERS USING [F-18]SULFONYL FLUORIDE AS A SOURCE OF [F-18]FLUORIDE | STX18, GPR119, SLC5A1 | GAA 268/4885CA1 881/4885CA9 307/4885 |
| US-11242314-B2 | Synthesizing pet tracers using [F-18]sulfonyl fluoride as a source of [F-18]fluoride | STX18, GPR119, SLC5A1 | GAA 268/4885CA1 881/4885CA9 307/4885 |
| US-20150367005-A1 | METHOD OF SYNTHESIZING FLUORINE-18 LABELED RADIOPHARMACEUTICALS IN ETHANOL AND WATER | TMEM14C, ADH1A, SELENOI | GAA 1392/4885CA1 978/4885CA9 724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.